The release of the cellular contents result in metabolic derangements such as hyper-uricemia, hyperkalemia, elevated LDH levels, hyperphosphatemia, acute renal failure and hypocalcaemia that characterize tumor lysis syndrome [2]. TLS commonly occurs with hematological malignancies but is rare with solid tumors due to relatively low proliferative index and marginal response to chemotherapy.

Solid tumors that are known to cause TLS include breast carcinoma [3], medullo-blastoma [4], ovarian cancer [5], rhabdomyosarcoma [6] and neuro-blastoma [7]. Typically these tumors are bulky with multiple Selleckchem PCI32765 metastatic foci and generally are sensitive to initial chemotherapy. TLS rarely occurs with small cell lung cancer [7], [8] and [9] which is more chemo-sensitive, but occurrence of TLS with NSCLC is extremely rare. This may be due to low proliferative rate and chemo-resistance of NSCLC. There have been only four case reports of TLS with NSCLC, and one of them died of acute spontaneous tumor lysis syndrome without chemotherapy. Stage IV NSCLC is associated with poor prognosis. In patients with good performance status chemotherapy improves survival by only 4 months with 1-year survival of 10–20% and 5-year survival of <5% [14]. Additionally expression of biomarker ki-67 in tumor like our

patient NLG919 in vitro is associated with poor outcome [15]. In this case report we describe a unique case of lung cancer with complete lysis of the tumor resulting

from chemotherapy leaving a large cystic lesion in the lung. He did not have metabolic derangements to suggest TLS. The possible explanation for the absence of TLS despite complete lysis of the tumor is that the size of the tumor was not large and bulky enough to cause the syndrome. However it is still possible that he might have had milder form of the TLS which was missed due to absence of symptoms. To our knowledge, this is the first case of lung Oxymatrine cancer with complete lysis of the tumor without tumor lysis syndrome. The study was performed at Jacobi Medical Center. This manuscript is not under consideration in any other journal. The authors declare that there was no funding for this study. All authors have read the manuscript and agree to the content. None. “
“Rheumatoid pleurisy is a well-known but relatively rare complication of rheumatoid arthritis (RA) that has been reported in fewer than 5% of RA patients [1] and [2]. It usually occurs during the course of a previously diagnosed RA but is occasionally seen contemporaneously with or preceding the onset of other arthritic signs and symptoms [2]. Consequently, a diagnosis of rheumatoid pleurisy may be delayed or even missed. We report a case involving a 50-year-old man without other arthritic symptoms whose RA-related pseudochylothorax was diagnosed by medical thoracoscopy.